Evidence map›Paper›PMID 40301356›Full record

ArticleNature communications2025

Enrichment of human IgA-coated bacterial vesicles in ulcerative colitis as a driver of inflammation.

Himadri B Thapa, Christina A Passegger, Dominik Fleischhacker, Paul Kohl, Yi-Chi Chen, Ratchara Kalawong, Carmen Tam-Amersdorfer, Michael R Gerstorfer, Jana Strahlhofer, Kristina Schild-Prüfert and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Frontiers in nutrition · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Himadri B ThapaInstitute of Molecular Biosciences, University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0001-8965-6716
Christina A PasseggerDivision of Immunology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria.
Dominik FleischhackerInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Paul KohlInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Yi-Chi ChenDepartment of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-3819-4085
Ratchara KalawongDepartment of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland.
Carmen Tam-AmersdorferDivision of Immunology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria.
Michael R GerstorferResearch Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria.
Jana StrahlhoferInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Kristina Schild-PrüfertInstitute of Molecular Biosciences, University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-0154-7310
Ellen L ZechnerInstitute of Molecular Biosciences, University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-2035-1898
Andreas BleslDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Lukas BinderDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Georg A BusslingerResearch Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0002-7851-9895
Leo EberlDepartment of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-7241-0864
Gregor GorkiewiczBioTechMed, Graz, Austria.ORCID http://orcid.org/0000-0003-1149-4782
Herbert StroblDivision of Immunology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-8070-4977
Christoph HögenauerBioTechMed, Graz, Austria. christoph.hoegenauer@medunigraz.at.ORCID http://orcid.org/0000-0003-4566-0806
Stefan SchildInstitute of Molecular Biosciences, University of Graz, Graz, Austria. stefan.schild@uni-graz.at.ORCID http://orcid.org/0000-0001-7842-0177

Funding

Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) DOC 50
6 · The paper itself

Abstract

The gut microbiome contributes to chronic inflammatory responses in ulcerative colitis (UC), but molecular mechanisms and disease-relevant effectors remain unclear. Here we analyze the pro-inflammatory properties of colonic fluid obtained during colonoscopy from UC and control patients. In patients with UC, we find that the pelletable effector fraction is composed mostly of bacterial extracellular vesicles (BEVs) that exhibit high IgA-levels and incite strong pro-inflammatory responses in IgA receptor-positive (CD89

Indexed as

Colitis, UlcerativeExtracellular VesiclesImmunoglobulin AInflammationAdultAnimalsAntigens, CDColonDextran SulfateDisease Models, AnimalFemaleGastrointestinal MicrobiomeHumansIntestinal MucosaMaleMiceAntigens, CDDextran SulfateImmunoglobulin A

Identifiers

PMID40301356
PMCPMC12041585

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.